Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SRP54 antisense RNA 1 (SRP54-AS1) is likely a non-coding RNA transcribed in the antisense direction relative to the SRP54 gene. There is no evidence from available sources that SRP54-AS1 is a protein, enzyme, receptor, transporter, or direct therapeutic target. Most available biomedical literature and databases reference SRP54, which encodes a 54-kDa subunit of the signal recognition particle involved in co-translational targeting of secretory and membrane proteins to the endoplasmic reticulum. Antisense RNAs such as SRP54-AS1 may have regulatory functions but are not generally considered tractable drug targets or receptors themselves. No established aliases, molecular family classifications, biological functions, or roles in disease are documented for SRP54-AS1 in major scientific literature or target databases. No drugs, biomarkers, or known safety concerns are linked to this transcript. All detailed functional and disease information is associated with the protein-coding gene SRP54, not the antisense RNA[1][2][3][4]. Key clarification: Requests for information on "SRP54 antisense RNA 1" likely stem from confusion with the well-characterized protein-coding gene SRP54. There is no substantive evidence in the results indicating that SRP54-AS1 is a receptor, membrane protein, classical therapeutic target, or well-studied functional RNA. If you intended to query SRP54, refer to entries and functions for "Signal recognition particle 54" instead[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SRP54 antisense RNA 1 (SRP54-AS1).